These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16042785)

  • 1. Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression.
    Oudes AJ; Roach JC; Walashek LS; Eichner LJ; True LD; Vessella RL; Liu AY
    BMC Cancer; 2005 Jul; 5():86. PubMed ID: 16042785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of differentially expressed genes in LNCaP prostate cancer progression model.
    Xie BX; Zhang H; Wang J; Pang B; Wu RQ; Qian XL; Yu L; Li SH; Shi QG; Huang CF; Zhou JG
    J Androl; 2011; 32(2):170-82. PubMed ID: 20864652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
    Bisoffi M; Klima I; Gresko E; Durfee PN; Hines WC; Griffith JK; Studer UE; Thalmann GN
    J Urol; 2004 Sep; 172(3):1145-50. PubMed ID: 15311059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
    Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.
    Trojan L; Schaaf A; Steidler A; Haak M; Thalmann G; Knoll T; Gretz N; Alken P; Michel MS
    Anticancer Res; 2005; 25(1A):183-91. PubMed ID: 15816537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cancer/testis-antigen genes by massively parallel signature sequencing.
    Chen YT; Scanlan MJ; Venditti CA; Chua R; Theiler G; Stevenson BJ; Iseli C; Gure AO; Vasicek T; Strausberg RL; Jongeneel CV; Old LJ; Simpson AJ
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7940-5. PubMed ID: 15905330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
    Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells.
    Mori R; Xiong S; Wang Q; Tarabolous C; Shimada H; Panteris E; Danenberg KD; Danenberg PV; Pinski JK
    Prostate; 2009 Jan; 69(1):12-23. PubMed ID: 18814146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression.
    Agell L; Hernández S; Nonell L; Lorenzo M; Puigdecanet E; de Muga S; Juanpere N; Bermudo R; Fernández PL; Lorente JA; Serrano S; Lloreta J
    Am J Pathol; 2012 Nov; 181(5):1585-94. PubMed ID: 23083832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution ERG-expression profiling on GeneChip exon 1.0 ST arrays in primary and castration-resistant prostate cancer.
    Smit FP; Salagierski M; Jannink S; Schalken JA
    BJU Int; 2013 May; 111(5):836-42. PubMed ID: 23578236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep and comparative analysis of the mycelium and appressorium transcriptomes of Magnaporthe grisea using MPSS, RL-SAGE, and oligoarray methods.
    Gowda M; Venu RC; Raghupathy MB; Nobuta K; Li H; Wing R; Stahlberg E; Couglan S; Haudenschild CD; Dean R; Nahm BH; Meyers BC; Wang GL
    BMC Genomics; 2006 Dec; 7():310. PubMed ID: 17156450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.
    Steele VE; Arnold JT; Lei H; Izmirlian G; Blackman MR
    Anticancer Res; 2006; 26(5A):3205-15. PubMed ID: 17094431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
    Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW
    Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray-based expression profiling in prostate tumors.
    Elek J; Park KH; Narayanan R
    In Vivo; 2000; 14(1):173-82. PubMed ID: 10757075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells.
    Fu Z; Dozmorov IM; Keller ET
    Prostate; 2002 Apr; 51(1):10-20. PubMed ID: 11920953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence biases in large scale gene expression profiling data.
    Siddiqui AS; Delaney AD; Schnerch A; Griffith OL; Jones SJ; Marra MA
    Nucleic Acids Res; 2006 Jul; 34(12):e83. PubMed ID: 16840527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
    Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
    Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical analysis of MPSS measurements: application to the study of LPS-activated macrophage gene expression.
    Stolovitzky GA; Kundaje A; Held GA; Duggar KH; Haudenschild CD; Zhou D; Vasicek TJ; Smith KD; Aderem A; Roach JC
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1402-7. PubMed ID: 15668391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR2 expression correlates with prostate cancer progression.
    Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
    J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.